Clinical research

The BioSTAR® device versus the CardioSEAL® device in patent foramen ovale closure: comparison of mid-term efficacy and safety

EuroIntervention 2010;6:498-504.

Ben J.L. Van den Branden
Ben J. Van den Branden*, MD; Justin G. Luermans, MD, PhD; Martijn C. Post, MD, PhD; Herbert W. Plokker, MD, PhD; Jurriën M. ten Berg, MD, PhD; Maarten J. Suttorp, MD, PhD
Department of Interventional Cardiology, St. Antonius Hospital, Nieuwegein, The Netherlands

Aims: To compare the mid-term efficacy and safety of the bioabsorbable BioSTAR® device with the non-bioabsorbable CardioSEAL® dev

Sign in to read and download the full article

Forgot your password?

No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

transcatheter closurepatent foramen ovaleresidual shunt
Read next article
The use of MSCT for the evaluation of the aortic root before transcutaneous aortic valve implantation: the Rotterdam approach

Latest news